ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DCTH vs ANGO // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Delcath Systems Inc. (NASDAQ) VS. AngioDynamics Inc. (NASDAQ) • 15-METRIC TALLY: DCTH 8 — ANGO 2
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DCTH VS. ANGO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DCTH ANGO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 86.20% 54.60% +31.60 DCTH /gross-margins <GO>
Return on Invested Capital (ROIC) 0.80% -23.40% +24.20 DCTH /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield 4.13% 0.10% +4.03 DCTH /fcf-yield <GO>
Operating Margin 0.80% -12.50% +13.30 DCTH /operating-margins <GO>
Net Profit Margin 3.20% -11.50% +14.70 DCTH /net-margins <GO>
Revenue Growth (YoY) 129.10% 9.50% +119.60 DCTH /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 20.33 2.12 +18.21 DCTH /balance-sheet <GO>
Piotroski F-Score Quality 8/9 6/9 +2.00 DCTH /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 37.3 39.4 -2.13 ANGO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $508.0M $519.4M -$11.4M ANGO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DCTH REV ANGO REV DCTH GROSS % ANGO GROSS % DCTH FCF ANGO FCF
FY 2025 $85.2M $320.2M 86.2% 54.6% $21.0M $508.0K
FY 2024 $37.2M $292.5M 83.4% 53.9% -$19.2M -$14.6M
FY 2023 $2.1M $303.9M — — -$31.3M -$28.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DCTH // BETA —
ANGO // BETA —